Filters
In patients with severe eosinophilic asthma, treatment with mepolizumab reduces exposure to toxic levels of oral corticosteroids (OCS) and, in turn, the incidence of associated complications, according to a real-world study.
Inhalation of a low-dose mixture of hydrogen and oxygen effectively improves sleep quality and mood through its antioxidant properties, by reducing wake time, enhancing sleep quality and relieving psychological stress, a Chinese study has found.
A single administration of MM120, a semisynthetic pharmaceutical formulation of lysergic acid diethylamide (LSD), helps ease symptoms in patients with moderate to severe generalized anxiety disorder (GAD), as shown in a phase IIB study.
Weekly treatment with semaglutide yields reductions in HbA1c and weight in schizophrenia patients with prediabetes and obesity without worsening mental health, according to a study.
Switching to a doravirine-based ARV regimen resolves neuropsychiatric AEs that were ongoing during a prior efavirenz-based regimen in DRIVE-AHEAD, with few events persisting 96 weeks after switching — a finding also seen in DRIVE-FORWARD, as shown in post hoc analyses of the OLEs of the two phase III trials
Children who spend more screen time are at increased risk of having more depressive symptoms, potentially due to shorter sleep and worse white matter organization during early adolescence, according to a study.
The use of selective dorsal neurectomy (SDN)/cryoablation (CA) as a treatment option for patients with premature ejaculation remains controversial, according to a study. SDN/CA affects intravaginal ejaculatory latency time (IELT) and patient satisfaction.
People with epilepsy often experience sleep disturbance, which is linked to other problems such as anxiety and depression and negatively affects quality of life (QoL), according to a study from Germany.
Smoking cessation is associated with sustained recovery from substance use disorders (SUDs), according to a longitudinal cohort study funded by the US National Institutes of Health (NIH).
Receiving a stimulant prescription for attention deficit hyperactivity disorder (ADHD) via telehealth shows no significant impact on the risk for substance use disorder (SUD) but appears to elevate the risk of subsequent stimulant use disorder (stimUD), suggests a study.
